Puref, LLC
Records under this name other than patents Puref, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Puref, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,180,616 | Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function Lapsed on the fee record Ended Jan 30, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2009 | From the USPTO record |
| US 6,642,209 | Use of adenosine compounds to alleviate or normalize pathologically hyperexcited sensory nerve function in a human patient Lapsed on the fee record Ended Nov 4, 2007 · From the USPTO record | Lapsed on the fee record | Ended Nov 4, 2007 | From the USPTO record |
| US 5,677,290 | Therapeutic use of adenosine compounds as surgical anesthetics Term ended Term ended no later than Oct 14, 2017 · Low confidence | Term ended | Term ended no later than Oct 14, 2017 | Low confidence |
| US 5,679,649 | Use of adenosine compounds for autonomic nervous system attenuation Term ended Term ended no later than Oct 21, 2017 · Low confidence | Term ended | Term ended no later than Oct 21, 2017 | Low confidence |
| US 6,004,945 | Use of adenosine compounds to relieve pain Term ended Term ended no later than Dec 21, 2019 · Low confidence | Term ended | Term ended no later than Dec 21, 2019 | Low confidence |